Amrutanjan Health Care Profit & Loss Annual

Trade
BSE: 590006 | NSE: AMRUTANJAN | ISIN: INE098F01031 | Sector: Biotechnology & Drugs
699.60 +1.70 (0.24%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 421.23379.64405.84332.84
Total Revenue 421.23379.64405.84332.84
Costof Revenue Total 211.83185.04183.13141.94
Gross Profit 209.40194.60222.72190.90
Selling/ General/ Admin Expenses Total 100.12109.49142.94115.82
Depreciation/ Amortization 6.065.213.803.67
Other Operating Expenses Total 57.4840.510.300.33
Total Operating Expense 375.48340.25330.16261.76
Operating Income 45.7539.3975.6871.08
Interest Inc( Exp) Net- Non- Op Total -1.57117.40110.8192.74
Other Net 16.352.493.821.46
Net Income Before Taxes 61.9553.6590.5881.90
Provisionfor Income Taxes 16.9713.8123.3920.71
Net Income After Taxes 44.9739.8367.1961.19
Net Income Before Extra Items 44.9739.8367.1961.19
Net Income 44.9739.8367.1961.19
Income Availableto Com Excl Extra Ord 44.9739.8367.1961.19
Income Availableto Com Incl Extra Ord 44.9739.8367.1961.19
Diluted Net Income 44.9739.8367.1961.19
Diluted Weighted Average Shares 2.902.922.922.92
Diluted EPS Excluding Extra Ord Items 15.5013.6322.9820.93
DPS- Common Stock Primary Issue 4.604.604.604.20
Diluted Normalized EPS 15.5013.6222.9820.91
Gain( Loss)on Saleof Assets -0.270.000.89
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts